- Home
- MKL vs DGX Comparison
MKL vs DGX Comparison
Compare MKL & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKL
- DGX
- Stock Information
- Founded
- MKL 1930
- DGX 1967
- Country
- MKL United States
- DGX United States
- Employees
- MKL N/A
- DGX N/A
- Industry
- MKL Property-Casualty Insurers
- DGX Medical Specialities
- Sector
- MKL Finance
- DGX Health Care
- Exchange
- MKL Nasdaq
- DGX Nasdaq
- Market Cap
- MKL 24.4B
- DGX 20.5B
- IPO Year
- MKL 1986
- DGX 1996
- Fundamental
- Price
- MKL $2,066.31
- DGX $187.93
- Analyst Decision
- MKL Hold
- DGX Buy
- Analyst Count
- MKL 2
- DGX 15
- Target Price
- MKL $1,930.50
- DGX $194.07
- AVG Volume (30 Days)
- MKL 45.4K
- DGX 1.2M
- Earning Date
- MKL 10-29-2025
- DGX 10-21-2025
- Dividend Yield
- MKL N/A
- DGX 1.71%
- EPS Growth
- MKL N/A
- DGX 14.49
- EPS
- MKL 142.27
- DGX 8.51
- Revenue
- MKL $16,210,307,000.00
- DGX $10,850,000,000.00
- Revenue This Year
- MKL N/A
- DGX $12.37
- Revenue Next Year
- MKL $0.39
- DGX $3.51
- P/E Ratio
- MKL $14.48
- DGX $21.96
- Revenue Growth
- MKL N/A
- DGX 13.74
- 52 Week Low
- MKL $1,621.89
- DGX $148.70
- 52 Week High
- MKL $2,109.91
- DGX $197.55
- Technical
- Relative Strength Index (RSI)
- MKL 64.62
- DGX 59.15
- Support Level
- MKL $1,943.75
- DGX $184.50
- Resistance Level
- MKL $2,109.91
- DGX $190.47
- Average True Range (ATR)
- MKL 38.07
- DGX 4.23
- MACD
- MKL 15.27
- DGX 1.14
- Stochastic Oscillator
- MKL 83.75
- DGX 75.99
About MKL Markel Group Inc.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.